The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
With the rise of biologics, sponsors are facing new challenges in how drugs are administered to patients. This is especially true in oncology studies, where intravenous infusion has become commonplace. Coupled with sites in remote areas of the world and a shift in responsibilities from sites to sponsors, the supply chain of ancillaries has never been more complex.
Learn how to:
- Eliminate the need to determine unnecessary site-specific supplies
- Save months of work for all parties
- Increase flexibility in the supply chain